featured
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the US and Europe: Randomized Clinical Trial
Gastroenterology 2022 Jun 06;[EPub Ahead of Print], WD Chey, F Mégraud, L Laine, LJ López, BJ Hunt, CW HowdenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.